Evaluating the Feasibility, Acceptability, and Initial Clinical Effectiveness of Implementing a Cognitive Remediation Program Within Psychiatric Services.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Royal Ottawa Mental Health Centre

About this trial

Severe and persistent mental health disorders are associated with impairments in cognitive, emotional, and social functioning. Some of these disorders involve cognitive challenges that are likely to negatively affect quality of life. In this context, the early identification of cognitive difficulties and intervention through cognitive remediation become priority therapeutic targets to facilitate individual rehabilitation. From this perspective, the present study aims to determine the relevance of a personalized cognitive remediation program developed by neuropsychologists at Pierre-Janet Hospital, called RECAMEX, to guide its sustainable adoption and to support its implementation in other clinical settings.

Eligibility criteria

Qualifiers

Aged 18 years or older.

Present cognitive difficulties in the context of a diagnosed severe and persistent mental illness.

Report recurrent complaints related to cognitive challenges affecting multiple areas of daily functioning.

Able to provide free and informed consent.

Disqualifiers

Intellectual disability diagnosis and confirmed in medical record.

A major medical condition other than the mental health disorder that affects cognitive functioning.

Trial design

Treatments tested in this trial

  • Cognitive remediation

Treatment groups

87 Participants
are divided into 2 treatment groups

Locations

This trial has no locations